硫利达嗪及其某些代谢产物与人血清蛋白和人白蛋白的结合。
Binding of thioridazine and some of its metabolites to human serum protein and human albumin.
作者信息
Belpaire F M, Vanderheeren F A, Bogaert M G
出版信息
Arzneimittelforschung. 1975;25(12):1969-71.
PMID:1243669
Abstract
The binding of thioridazine and some of its psychoactive metabolites to human serum and to human albumin was studied using equilibrium dialysis. A very important binding capacity was found for each of the products tested, but significant differences between binding to human serum and binding to human albumin were observed.
摘要
使用平衡透析法研究了硫利达嗪及其一些精神活性代谢产物与人血清和人白蛋白的结合情况。在所测试的每种产物中都发现了非常重要的结合能力，但观察到与人血清的结合和与人白蛋白的结合之间存在显著差异。
相似文献
1
Binding of thioridazine and some of its metabolites to human serum protein and human albumin.硫利达嗪及其某些代谢产物与人血清蛋白和人白蛋白的结合。
Arzneimittelforschung. 1975;25(12):1969-71.
2
Albumin binding of thioridazine and some of its metabolites.硫利达嗪及其某些代谢物的白蛋白结合情况。
Arch Int Pharmacodyn Ther. 1975 Mar;214(1):86-91.
3
Partitioning of thioridazine and mesoridazine in human blood fractions.硫利达嗪和美索达嗪在人体血液组分中的分配
Methods Find Exp Clin Pharmacol. 1984 Mar;6(3):143-6.
4
Studies on thioridazine and mesoridazine metabolism. I. Protein binding.硫利达嗪和甲砜达嗪代谢的研究。I. 蛋白质结合。
Commun Psychopharmacol. 1979;3(5):319-22.
5
Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.硫利达嗪及其代谢产物与精神病患者血清蛋白的结合情况。
Eur J Clin Pharmacol. 1978 Dec 18;14(5):341-50. doi: 10.1007/BF00611904.
6
Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.3-乙氧羰基补骨脂素与人血清白蛋白及人血清的结合：游离脂肪酸的影响
Rev Esp Fisiol. 1987 Sep;43(3):317-21.
7
Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.硫利达嗪和甲砜达嗪代谢的研究。II. 恒河猴体内氚标记药物的代谢
Commun Psychopharmacol. 1979;3(5):323-7.
8
Propofol binding to human blood proteins.丙泊酚与人体血液蛋白的结合。
Arzneimittelforschung. 1995 Oct;45(10):1053-6.
9
Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.硫利达嗪及其代谢产物在大鼠急性和慢性治疗后血浆和脑中的药代动力学。
Pol J Pharmacol. 1997 Nov-Dec;49(6):439-52.
10
Theophylline protein binding.
Arzneimittelforschung. 1990 Feb;40(2 Pt 1):166-9.
引用本文的文献
1
Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.抗精神病药物对I(to)、I(Na)、I(sus)、I(K1)和hERG的影响：QT间期延长、构效关系及网络分析
Pharm Res. 2006 Jun;23(6):1133-43. doi: 10.1007/s11095-006-0070-7. Epub 2006 May 25.
2
Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
Eur J Clin Pharmacol. 1977 Jan 3;11(2):135-40. doi: 10.1007/BF00562905.
3
Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.硫利达嗪及其代谢产物与精神病患者血清蛋白的结合情况。
Eur J Clin Pharmacol. 1978 Dec 18;14(5):341-50. doi: 10.1007/BF00611904.
4
Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.四种抗精神病药物的心脏电生理学：美哌隆、氟哌啶醇、硫利达嗪和氯丙嗪。
Naunyn Schmiedebergs Arch Pharmacol. 1978 Aug;304(1):27-36. doi: 10.1007/BF00501374.
5
Plasma level monitoring of antipsychotic drugs.抗精神病药物的血药浓度监测
Clin Pharmacokinet. 1978 Jan-Feb;3(1):14-38. doi: 10.2165/00003088-197803010-00002.
Zotero 插件